Sees FY25 capital expenditures $1.27B. Sees FY25 effective tax rate 15%-20%. Sees FY25 increase in energy deliveries of 2.5%-3.5%.Maximize Your ...

The Oakland-based company posted a profit of $1.15 a share in 2024. For 2025, PG&E predicts that its profits will range from ...

Pfizer faces revenue decline from patent expirations, profitability challenges, and bearish technicals. Learn why PFE stock ...

Pfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the past ...

Since the beginning of 2024, PFE stock has underperformed the S&P 500 index, delivering -3% returns compared to the index’s ...

Pfizer Inc. (PFE) is my Top Pick for income-oriented investors in 2025. The past year was unkind to the pharmaceutical giant because it does not have diabetes or weight loss drugs in its portfolio.

Earnings season is in full swing in the pharma sector with major players sharing their latest results. On Tuesday (February 4 ...

Stocks are struggling for direction today, and one sector that represents this choppiness is blue-chip drugmakers. Merck & Co ...

LONDON (AP) — Five years ago Friday, two crowds of people gathered near Britain’s Parliament — some with Union Jacks and cheers, others European Union flags and tears. On Jan. 31 ...

Mind, Body, Spirit took a 7.1% hit down to £18.2m, though that is still £5-£10m better than what the category earned in any year during the 2010s. The more, er, woo-woo end suffered here ...